This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Balliet, J. W. Articles by Bates, P. Search for Related Content PubMed PubMed Citation Articles by Balliet, J. W. Articles by Bates, P.

 Previous Article  |  Next Article 

J Virol, January 1998, p. 671-676, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Efficient Infection Mediated by Viral Receptors Incorporated into Retroviral Particles

John W. Balliet and Paul Bates^*

Department of Microbiology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-4318

Received 21 August 1997/Accepted 30 September 1997

Many host cell surface proteins, including viral receptors, are incorporated into enveloped viruses. To address the functional significance of these host proteins, murine leukemia viruses containing the cellular receptors for Rous sarcoma virus (Tva) or ecotropic murine leukemia virus (MCAT-1) were produced. These receptor-pseudotyped viruses efficiently infect cells expressing the cognate viral envelope glycoproteins, with titers of up to 10⁵ infectious units per milliliter for the Tva pseudotypes. Receptor and viral glycoprotein specificity and functional requirements are maintained, suggesting that receptor pseudotype infection recapitulates events of normal viral entry. The ability of the Tva and MCAT-1 pseudotypes to infect cells efficiently suggests that, in contrast to human immunodeficiency virus type 1 entry, neither of these retroviral receptors requires a coreceptor for membrane fusion. In addition, the ability of receptor pseudotypes to target infected cells suggests that they may be useful therapeutic reagents for directing infection of viral vectors. Receptor-pseudotyped viruses may be useful for identifying new viral receptors or for defining functional requirements of known receptors. Moreover, this work suggests that the production of receptor pseudotypes in vivo could provide a mechanism for expanded viral tropism with potential effects on the pathogenesis and evolution of the virus.

---

^* Corresponding author. Mailing address: Department of Microbiology, School of Medicine, University of Pennsylvania, 201c Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104-6076. Phone: (215) 573-3509. Fax: (215) 573-4184. E-mail: pbates{at}mail.med.upenn.edu.

This article has been cited by other articles:

• Pizzato, M., Popova, E., Gottlinger, H. G. (2008). Nef Can Enhance the Infectivity of Receptor-Pseudotyped Human Immunodeficiency Virus Type 1 Particles. J. Virol. 82: 10811-10819 [Abstract] [Full Text]  
• Jones, J. W., Greene, T. A., Grygon, C. A., Doranz, B. J., Brown, M. P. (2008). Cell-Free Assay of G-Protein-Coupled Receptors Using Fluorescence Polarization. J Biomol Screen 13: 424-429 [Abstract]  
• Ye, K., Jin, S., Ataai, M. M., Schultz, J. S., Ibeh, J. (2004). Tagging Retrovirus Vectors with a Metal Binding Peptide and One-Step Purification by Immobilized Metal Affinity Chromatography. J. Virol. 78: 9820-9827 [Abstract] [Full Text]  
• Zhou, J., Aiken, C. (2001). Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity Resulting from Intervirion Fusion: Evidence Supporting a Role for Nef at the Virion Envelope. J. Virol. 75: 5851-5859 [Abstract] [Full Text]  
• Zeilfelder, U., Bosch, V. (2001). Properties of Wild-Type, C-Terminally Truncated, and Chimeric Maedi-Visna Virus Glycoprotein and Putative Pseudotyping of Retroviral Vector Particles. J. Virol. 75: 548-555 [Abstract] [Full Text]  
• Hoffman, T. L., Canziani, G., Jia, L., Rucker, J., Doms, R. W. (2000). A biosensor assay for studying ligand-membrane receptor interactions: Binding of antibodies and HIV-1 Env to chemokine receptors. Proc. Natl. Acad. Sci. USA 10.1073/pnas.190274097v1 [Abstract] [Full Text]  
• Damico, R., Bates, P. (2000). Soluble Receptor-Induced Retroviral Infection of Receptor-Deficient Cells. J. Virol. 74: 6469-6475 [Abstract] [Full Text]  
• Somia, N. V., Miyoshi, H., Schmitt, M. J., Verma, I. M. (2000). Retroviral Vector Targeting to Human Immunodeficiency Virus Type 1-Infected Cells by Receptor Pseudotyping. J. Virol. 74: 4420-4424 [Abstract] [Full Text]  
• Holmen, S. L., Salter, D. W., Payne, W. S., Dodgson, J. B., Hughes, S. H., Federspiel, M. J. (1999). Soluble Forms of the Subgroup A Avian Leukosis Virus [ALV(A)] Receptor Tva Significantly Inhibit ALV(A) Infection In Vitro and In Vivo. J. Virol. 73: 10051-10060 [Abstract] [Full Text]  
• Balliet, J. W., Berson, J., D'Cruz, C. M., Huang, J., Crane, J., Gilbert, J. M., Bates, P. (1999). Production and Characterization of a Soluble, Active Form of Tva, the Subgroup A Avian Sarcoma and Leukosis Virus Receptor. J. Virol. 73: 3054-3061 [Abstract] [Full Text]  
• Rong, L., Gendron, K., Strohl, B., Shenoy, R., Wool-Lewis, R. J., Bates, P. (1998). Characterization of Determinants for Envelope Binding and Infection in Tva, the Subgroup A Avian Sarcoma and Leukosis Virus Receptor. J. Virol. 72: 4552-4559 [Abstract] [Full Text]  
• Damico, R. L., Crane, J., Bates, P. (1998). Receptor-triggered membrane association of a model retroviral glycoprotein. Proc. Natl. Acad. Sci. USA 95: 2580-2585 [Abstract] [Full Text]  
• Hoffman, T. L., Canziani, G., Jia, L., Rucker, J., Doms, R. W. (2000). A biosensor assay for studying ligand-membrane receptor interactions: Binding of antibodies and HIV-1 Env to chemokine receptors. Proc. Natl. Acad. Sci. USA 97: 11215-11220 [Abstract] [Full Text]